Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window

Infection and Immunity

Volumn 83, Issue 5, 2015, Pages 1853-1868

  Singh, Alok Kumar ^a   Pandey, Rajeev Kumar ^b   Siqueira Neto, Jair Lage ^c,d   Kwon, Yong Jun ^c,e   Freitas Junior, Lucio H ^c,f   Shaha, Chandrima ^b   Madhubala, Rentala ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c Institute Pasteur Korea   (South Korea)

^d University of California at San Francisco   (United States)

^e Samsung Medical Center   (South Korea)

^f BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA INTERFERON; BETA INTERFERON; CASPASE 3; CASPASE 7; GRANZYME A; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPHOSPHOGLYCAN; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MITOCHONDRIAL PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN CDC42; RAC1 PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RNA BINDING PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PROTEOME;

ACUTE MONOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL METABOLISM; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC TRANSCRIPTION; GLYCOLYSIS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; LEISHMANIA DONOVANI; LEISHMANIASIS; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SPLICING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TANDEM MASS SPECTROMETRY; CELL LINE; CHEMISTRY; IMMUNOLOGY; MACROPHAGE; PARASITOLOGY;

CELL LINE; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; LEISHMANIA DONOVANI; MACROPHAGES; PROTEOME; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY;

EID: 84928187237     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02833-14     Document Type: Article

References (74)

1. Herwaldt BL. 1999. Leishmaniasis. Lancet 354:1191-1199.
2. Bogdan C, Röllinghoff M. 1999. How do protozoan parasites survive inside macrophages? Parasitol Today 15:22-28. http://dx.doi.org/10.1016/S0169-4758(98)01362-3.
3. Olivier M, Gregory DJ, Forget G. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18:293-305. http://dx.doi.org/10.1128/CMR.18.2.293-305.2005.
4. Proudfoot L, O'Donnell CA, Liew FY. 1995. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol 25:745-750. http://dx.doi.org/10.1002/eji.1830250318.
5. Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, Olivier M. 2001. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol 31:3185-3196. http://dx.doi.org/10.1002/1521-4141(200111)31:11<3185::AID-IMMU3185>3.0.CO;2-J.
6. Moore KJ, Matlashewski G. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 152:2930-2937.
7. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183:515-526. http://dx.doi.org/10.1084/jem.183.2.515.
8. Reiner NE. 1987. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. J Immunol 138:1919-1925.
9. Descoteaux A, Matlashewski G, Turco SJ. 1992. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 149:3008-3015.
10. Martiny A, Meyer-Fernandes JR, de Souza W, Vannier-Santos MA. 1999. Altered tyrosine phosphorylation of ERK1 MAP kinase and other macrophage molecules caused by Leishmania amastigotes. Mol Biochem Parasitol 102:1-12. http://dx.doi.org/10.1016/S0166-6851(99)00067-5.
11. Buates S, Matlashewski G. 2001. General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol 166:3416-3422. http://dx.doi.org/10.4049/jimmunol.166.5.3416.
12. Gregory DJ, Sladek R, Olivier M, Matlashewski G. 2008. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun 76:1186-1192. http://dx.doi.org/10.1128/IAI.01320-07.
13. Guerfali FZ, Laouini D, Guizani-Tabbane L, Ottones F, Ben-Aissa K, Benkahla A, Manchon L, Piquemal D, Smandi S, Mghirbi O, Commes T, Marti J, Dellagi K. 2008. Simultaneous gene expression profiling in human macrophages infected with Leishmania major parasites using SAGE. BMC Genomics 9:238. http://dx.doi.org/10.1186/1471-2164-9-238.
14. Ramírez C, Díaz-Toro Y, Tellez J, Castilho TM, Rojas R, Ettinger NA, Tikhonova I, Alexander ND, Valderrama L, Hager J, Wilson ME, Lin A, Zhao H, Saravia NG, McMahon-Pratt D. 2012. Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis 6:e1866. http://dx.doi.org/10.1371/journal.pntd.0001866.
15. Menezes JPB, Almeida TF, Petersen ALOA, Guedes CES, Mota MSV, Lima JGB, Palma LC, Buck GA, Krieger MA, Probst CM, Veras PST. 2013. Proteomic analysis reveals differentially expressed proteins in macrophages infected with Leishmania amazonensis or Leishmania major. Microbes Infect 15:579-591. http://dx.doi.org/10.1016/j.micinf.2013.04.005.
16. Rose SJ, Bermudez LE. 2014. Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection. Infect Immun 82:405-412. http://dx.doi.org/10.1128/IAI.00820-13.
17. Biswas D, Qureshi OS, Lee W-Y, Croudace JE, Mura M, Lammas DA. 2008. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol 9:35. http://dx.doi.org/10.1186/1471-2172-9-35.
18. Cheekatla SS, Aggarwal A, Naik S. 2012. mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med Microbiol Immunol 201:37-46. http://dx.doi.org/10.1007/s00430-011-0202-5.
19. Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R. 2007. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59:204-211. http://dx.doi.org/10.1093/jac/dkl494.
20. Sharma A, Madhubala R. 2009. Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani. J Immunol 183:7719-7731. http://dx.doi.org/10.4049/jimmunol.0900132.
21. Alanne-Kinnunen M, Lappalainen J, Öörni K, Kovanen PT. 2014. Activated human mast cells induce LOX-1-specific scavenger receptor expression in human monocyte-derived macrophages. PLoS One 9:e108352. http://dx.doi.org/10.1371/journal.pone.0108352.
22. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA. 2007. The Paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6:1638-1655. http://dx.doi.org/10.1074/mcp.T600050-MCP200.
23. Martin B, Brenneman R, Becker KG, Gucek M, Cole RN, Maudsley S. 2008. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease. PLoS One 3:e2750. http://dx.doi.org/10.1371/journal.pone.0002750.
24. Siqueira-Neto JL, Moon S, Jang J, Yang G, Lee C, Moon HK, Chatelain E, Genovesio A, Cechetto J, Freitas-Junior LH. 2012. An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLoS Negl Trop Dis 6:e1671. http://dx.doi.org/10.1371/journal.pntd.0001671.
25. Kenedy MR, Vuppala SR, Siegel C, Kraiczy P, Akins DR. 2009. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77:2773-2782. http://dx.doi.org/10.1128/IAI.00318-09.
26. Kandasamy K, Keerthikumar S, Goel R, Mathivanan S, Patankar N, Shafreen B, Renuse S, Pawar H, Ramachandra YL, Acharya PK, Ranganathan P, Chaerkady R, Keshava Prasad TS, Pandey A. 2009. Human Proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res 37:D773-D781. http://dx.doi.org/10.1093/nar/gkn701.
27. Prasad TSK, Kandasamy K, Pandey A. 2009. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol 577:67-79. http://dx.doi.org/10.1007/978-1-60761-232-2_6.
28. Nelson MM, Jones AR, Carmen JC, Sinai AP, Burchmore R, Wastling JM. 2008. Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect Immun 76:828-844. http://dx.doi.org/10.1128/IAI.01115-07.
29. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291-336. http://dx.doi.org/10.1146/annurev.biochem.72.121801.161720.
30. Tazi J, Bakkour N, Stamm S. 2009. Alternative splicing and disease. Biochim Biophys Acta 1792:14-26. http://dx.doi.org/10.1016/j.bbadis.2008.09.017.
31. Michelotti EF, Michelotti GA, Aronsohn AI, Levens D. 1996. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 16:2350-2360.
32. Van Domselaar R, Quadir R, van der Made AM, Broekhuizen R, Bovenschen N. 2012. All human granzymes target hnRNP K that is essential for tumor cell viability. J Biol Chem 287:22854-22864. http://dx.doi.org/10.1074/jbc.M112.365692.
33. Xiao Z, Ko HL, Goh EH, Wang B, Ren EC. 2013. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors. Carcinogenesis 34:1458-1467. http://dx.doi.org/10.1093/carcin/bgt085.
34. Ng LFP, Chan M, Chan S-H, Cheng PC-P, Leung EH-C, Chen W-N, Ren E-C. 2005. Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. PLoS Med 2:e163. http://dx.doi.org/10.1371/journal.pmed.0020163.
35. Fan B, Lu K-Y, Reymond Sutandy FX, Chen Y-W, Konan K, Zhu H, Kao CC, Chen C-S. 2014. A human proteome microarray identifies that the heterogeneous nuclear ribonucleoprotein K (hnRNP K) recognizes the 5' terminal sequence of the hepatitis C virus RNA. Mol Cell Proteomics 13:84-92. http://dx.doi.org/10.1074/mcp.M113.031682.
36. Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM. 1994. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 179:447-456. http://dx.doi.org/10.1084/jem.179.2.447.
37. Hatzigeorgiou DE, Geng J, Zhu B, Zhang Y, Liu K, Rom WN, Fenton MJ, Turco SJ, Ho JL. 1996. Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence. Proc Natl Acad Sci U S A 93:14708-14713. http://dx.doi.org/10.1073/pnas.93.25.14708.
38. Kawada M, Hachiya Y, Arihiro A, Mizoguchi E. 2007. Role of mammalian chitinases in inflammatory conditions. Keio J Med 56:21-27. http://dx.doi.org/10.2302/kjm.56.21.
39. Chen C-C, Llado V, Eurich K, Tran HT, Mizoguchi E. 2011. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol 140:268-275. http://dx.doi.org/10.1016/j.clim.2011.04.007.
40. Lunter PC, van Kilsdonk JWJ, van Beek H, Cornelissen IMHA, Bergers M, Willems PHGM, van Muijen GNP, Swart GWM. 2005. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res 65:8801-8808. http://dx.doi.org/10.1158/0008-5472.CAN-05-0378.
41. Seth RB, Sun L, Ea C-K, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
42. Buss C, Opitz B, Hocke AC, Lippmann J, van Laak V, Hippenstiel S, Krüll M, Suttorp N, Eitel J. 2010. Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells. J Immunol 184:3072-3078. http://dx.doi.org/10.4049/jimmunol.0902947.
43. Belardelli F, Gresser I. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today 17:369-372. http://dx.doi.org/10.1016/0167-5699(96)10027-X.
44. Mattner J, Schindler H, Diefenbach A, Röllinghoff M, Gresser I, Bogdan C. 2000. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur J Immunol 30:2257-2267. http://dx.doi.org/10.1002/1521-4141(2000)30:8<2257::AID-IMMU2257>3.0.CO;2-U.
45. Favila MA, Geraci NS, Zeng E, Harker B, Condon D, Cotton RN, Jayakumar A, Tripathi V, McDowell MA. 2014. Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction. J Immunol 192:5863-5872. http://dx.doi.org/10.4049/jimmunol.1203230.
46. Belgnaoui SM, Paz S, Hiscott J. 2011. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 23:564-572. http://dx.doi.org/10.1016/j.coi.2011.08.001.
47. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635. http://dx.doi.org/10.1038/nature01148.
48. Morehead J, Coppens I, Andrews NW. 2002. Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis. Infect Immun 70:4571-4580. http://dx.doi.org/10.1128/IAI.70.8.4571-4580.2002.
49. Niu J, Profirovic J, Pan H, Vaiskunaite R, Voyno-Yasenetskaya T. 2003. G protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production. Circ Res 93:848-856. http://dx.doi.org/10.1161/01.RES.0000097607.14733.0C.
50. Zhang ZY. 2001. Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 5:416-423. http://dx.doi.org/10.1016/S1367-5931(00)00223-4.
51. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L. 2000. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 9:2297-2304. http://dx.doi.org/10.1093/oxfordjournals.hmg.a018921.
52. Contreras I, Gómez MA, Nguyen O, Shio MT, McMaster RW, Olivier M. 2010. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog 6:e1001148. http://dx.doi.org/10.1371/journal.ppat.1001148.
53. Shindo R, Kakehashi H, Okumura K, Kumagai Y, Nakano H. 2013. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation. Biochem Biophys Res Commun 436:212-216. http://dx.doi.org/10.1016/j.bbrc.2013.05.075.
54. Lodge R, Descoteaux A. 2005. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania. Clin Immunol 114:256-265. http://dx.doi.org/10.1016/j.clim.2004.07.018.
55. Pieters J. 2008. Coronin 1 in innate immunity. Subcell Biochem 48:116-123. http://dx.doi.org/10.1007/978-0-387-09595-0_11.
56. Seto S, Tsujimura K, Koide Y. 2012. Coronin-1a inhibits autophagosome formation around Mycobacterium tuberculosis-containing phagosomes and assists mycobacterial survival in macrophages. Cell Microbiol 14:710-727. http://dx.doi.org/10.1111/j.1462-5822.2012.01754.x.
57. Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G. 2011. Cyclic AMP: a selective modulator of NF-κB action. Cell Mol Life Sci 68:3823-3841. http://dx.doi.org/10.1007/s00018-011-0757-8.
58. Heussler VT, Küenzi P, Rottenberg S. 2001. Inhibition of apoptosis by intracellular protozoan parasites. Int J Parasitol 31:1166-1176. http://dx.doi.org/10.1016/S0020-7519(01)00271-5.
59. Trapani JA, Smyth MJ. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747. http://dx.doi.org/10.1038/nri911.
60. Gerke V, Creutz CE, Moss SE. 2005. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6:449-461. http://dx.doi.org/10.1038/nrm1661.
61. Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL. 2001. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 8:443-450. http://dx.doi.org/10.1038/sj.cdd.4400840.
62. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. 2003. Vimentin is secreted by activated macrophages. Nat Cell Biol 5:59-63. http://dx.doi.org/10.1038/ncb898.
63. Gladue DP, O'Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM, Fernández Sainz I, Lu Z, Ambroggio X, Rodriguez L, Borca MV. 2013. Foot-and-mouth disease virus modulates cellular vimentin for virus survival. J Virol 87:6794-6803. http://dx.doi.org/10.1128/JVI.00448-13.
64. Reeves R. 2001. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277:63-81. http://dx.doi.org/10.1016/S0378-1119(01)00689-8.
65. Maruyama T, Nara K, Yoshikawa H, Suzuki N. 2007. Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells. Clin Exp Immunol 147:164-175. http://dx.doi.org/10.1111/j.1365-2249.2006.03249.x.
66. Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein D. 2008. Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22:590-602. http://dx.doi.org/10.1096/fj.07-9254com.
67. Sardar AH, Kumar S, Kumar A, Purkait B, Das S, Sen A, Kumar M, Sinha KK, Singh D, Equbal A, Ali V, Das P. 2013. Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses. J Proteomics 81:185-199. http://dx.doi.org/10.1016/j.jprot.2013.01.011.
68. Lamour SD, Choi B-S, Keun HC, Müller I, Saric J. 2012. Metabolic characterization of Leishmania major infection in activated and nonactivated macrophages. J Proteome Res 11:4211-4222. http://dx.doi.org/10.1021/pr3003358.
69. McConville MJ, de Souza D, Saunders E, Likic VA, Naderer T. 2007. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol 23:368-375. http://dx.doi.org/10.1016/j.pt.2007.06.009.
70. Spasojević I, Mojović M, Blagojević D, Spasić SD, Jones DR, Nikolić-Kokić A, Spasić MB. 2009. Relevance of the capacity of phosphorylated fructose to scavenge the hydroxyl radical. Carbohydr Res 344:80-84. http://dx.doi.org/10.1016/j.carres.2008.09.025.
71. Mittra B, Andrews NW. 2013. IRONy OF FATE: role of iron-mediated ROS in Leishmania differentiation. Trends Parasitol 29:489-496. http://dx.doi.org/10.1016/j.pt.2013.07.007.
72. Steták A, Veress R, Ovádi J, Csermely P, Kéri G, Ullrich A. 2007. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res 67:1602-1608. http://dx.doi.org/10.1158/0008-5472.CAN-06-2870.
73. Singh AK, Mukhopadhyay C, Biswas S, Singh VK, Mukhopadhyay CK. 2012. Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. PLoS One 7:e38489. http://dx.doi.org/10.1371/journal.pone.0038489.
74. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, Cole RN, Pandey A, Semenza GL. 2011. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145:732-744. http://dx.doi.org/10.1016/j.cell.2011.03.054.